Adulterant
harm-reductionA substance present in a product other than the one it is sold as, whether added to bulk it out or imitate it, or arriving through contaminated manufacture. Reagent testing gives a presumptive check on what is present but cannot rule out everything else in a sample; identifying an adulterant reliably takes laboratory analysis.
An adulterant is any substance found in a drug supply that is not the compound being sold. Adulterants are added intentionally — to increase bulk, lower cost, or imitate the target drug's appearance or effects — or arrive through cross-contamination in shared manufacturing equipment.
The range is wide. Some adulterants are pharmacologically inert: sugars, starches, or binders that dilute potency without adding direct risk. Others carry their own pharmacological activity. A stimulant supply adulterated with a different stimulant, or an opioid supply containing a far more potent opioid, introduces risks that neither the seller nor the buyer may know exist.
How it is done
Several methods exist for checking a sample for adulterants before use. Colorimetric reagent tests — where a small amount of material is exposed to a reactive chemical that produces a colour response — can indicate the presence of broad compound classes. Fentanyl test strips, which detect opioid compounds in a dissolved sample, are now widely available outside laboratory settings.
Drug checking services, where available, send material to analysts using techniques such as gas chromatography–mass spectrometry or infrared spectroscopy, and return a more detailed account of what is present. These services can identify multiple compounds in a single sample, estimate their relative proportions, and flag components that reagent tests would not detect.
What it cannot tell you
No single screening method identifies everything present in a sample. Colorimetric reagents react to compound classes, not individual substances; a colour change consistent with an opioid does not distinguish between opioids within that class, and a clean reaction for one class does not rule out unrelated adulterants.
Fentanyl test strips detect opioid-class compounds at low concentrations, but a negative result means that opioids were not detected above the strip's threshold — not that a sample is free of adulterants in general. Some analogue compounds that differ slightly in structure may not trigger the strip at all.
Even laboratory analysis describes only the portion of a sample tested. Adulteration is not always uniform through a batch, so the tested quantity can differ meaningfully from the remainder. A result is a snapshot of one portion, not a statement about the whole supply.
The failure mode that matters most is treating a reassuring result as confirmation. A clean reagent test or a negative strip establishes what was detected — it does not establish what else is present, or what the concentration of any compound is.
AI-generated · not yet verified by a human reviewer
Harm-reduction reference — not medical advice.